Axil Capital
Asia, Tokyo, Japan, Tokyo
Description
Axil Capital is a venture capital firm investing in companies in the biomedical and healthcare fields from the early stages.
Investor Profile
Axil Capital has backed more than 8 startups, with 3 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, Japan, Israel.
- Strong thematic focus on Health Care, Medical, Biotechnology.
Stage Focus
- Series B (50%)
- Series Unknown (25%)
- Series A (13%)
- Series C (13%)
Country Focus
- United States (38%)
- Japan (38%)
- Israel (25%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Health Diagnostics
- Pharmaceutical
- Oncology
- Therapeutics
- Genetics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
